Graphdiyne Oxide-Mediated Photodynamic Therapy Boosts Enhancive T-Cell Immune Responses by Increasing Cellular Stiffness

被引:13
作者
Zhang, Lejia [1 ]
Pan, Kuangwu [1 ]
Huang, Siyuan [1 ]
Zhang, Xiliu [1 ]
Zhu, Xinyu [1 ]
He, Yi [1 ]
Chen, Xun [1 ]
Tang, Yuquan [1 ]
Yuan, Lingyu [1 ]
Yu, Dongsheng [1 ]
机构
[1] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Guangdong Prov Key Lab Stomatol, Guangzhou, Peoples R China
来源
INTERNATIONAL JOURNAL OF NANOMEDICINE | 2023年 / 18卷
基金
中国国家自然科学基金;
关键词
graphdiyne oxide; photodynamic therapy; stiffness; immunotherapy; cytotoxic T lymphocytes; oral squamous cell carcinoma cells; CANCER-CELLS; CHOLESTEROL; MEMBRANE; IMMUNOTHERAPY; MICROENVIRONMENT; EXTRACTION; NANOSHEETS; FORCE; SHIFT;
D O I
10.2147/IJN.S392998
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Purpose: Nanomaterial-based photodynamic therapy (PDT) has been commonly used for the treatment of cancerous tumors. Despite significant achievements made in this field, the intrinsic impact of nanomaterials-based PDT on the mechanical properties of oral squamous cell carcinoma (OSCC) cells is not entirely understood. Here, we used atomic force microscopy (AFM) to measure the stiffness of OSCC cells subjected to PDT in co-culture systems to evaluate the T cell-mediated cancer cell-killing effects.Methods: In this study, AFM was used to assess the stiffness of PDT-subjected cells. The phototoxicity of graphdiyne oxide (GDYO) was assessed using confocal laser scanning microscopy (CLSM), measurements of membrane cholesterol levels, and assessments of the F-actin cytoskeleton. A co-culture system was used to evaluate the effects of CD8+ T cells (cytotoxic T lymphocytes), demonstrating how PDT modulates the mechanical properties of cancer cells and activates T cell responses. The antitumor immunotherapeutic effect of GDYO was further evaluated in a murine xenograft model.Results: GDYO increased the mechanical stiffness of tumor cells and augmented T-cell cytotoxicity and inflammatory cytokine secretion (IFN-gamma and TNF-alpha) under laser in vitro. Furthermore, GDYO-based PDT exerted inhibitory effects on OSCC models and elicited antitumor immune responses via specific cytotoxic T cells.Conclusion: These results highlight that GDYO is a promising candidate for OSCC therapy, shifting the mechanical forces of OSCC cells and breaking through the barriers of the immunosuppressive tumor microenvironment. Our study provides a novel perspective on nanomaterial-based antitumor therapies.
引用
收藏
页码:797 / 812
页数:16
相关论文
共 10 条
  • [1] γδ T cell-mediated immune responses in disease and therapy
    Latha, T. Sree
    Reddy, Madhava C.
    Durbaka, Prasad V. R.
    Rachamallu, Aparna
    Pallu, Reddanna
    Lomada, Dakshayani
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [2] Photodynamic therapy of cutaneous T-cell lymphoma cell lines mediated by 5-aminolevulinic acid and derivatives
    Vallecorsa, Pablo
    Di Venosa, Gabriela
    Gola, Gabriel
    Saenz, Daniel
    Mamone, Leandro
    MacRobert, Alexander J.
    Ramirez, Javier
    Casas, Adriana
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2021, 221
  • [3] Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D in vitro heterocellular model of pancreatic cancer
    De Silva, Pushpamali
    Bano, Shazia
    Pogue, Brian W.
    Wang, Kenneth K.
    Maytin, Edward, V
    Hasan, Tayyaba
    NANOPHOTONICS, 2021, 10 (12) : 3199 - 3214
  • [4] Rational combinations of in vivo cancer antigen priming and adoptive T-cell therapy mobilize immune and clinical responses in terminal cancers
    Ruan, Qing Zhao
    Fu, Jian Qian
    Wu, Xiao Xuan
    Huang, Li Ping
    Ruan, Run Sheng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (06) : 907 - 915
  • [5] Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma
    Wysocka, Maria
    Dawany, Noor
    Benoit, Bernice
    Kossenkov, Andrew V.
    Troxel, Andrea B.
    Gelfand, Joel M.
    Sell, Michael Kelly
    Showe, Louise C.
    Rook, Alain H.
    LEUKEMIA & LYMPHOMA, 2011, 52 (10) : 1970 - 1979
  • [6] BATF-mediated regulation of exhausted CD8+ T-cell responses and potential implications for chimeric antigen receptor-T therapy
    Sun, Chao
    Li, Dan
    Wang, Zhengxin
    IMMUNOTHERAPY, 2024, 16 (05) : 331 - 340
  • [7] A Pan-Inhibitor of DASH Family Enzymes Induces Immune-mediated Regression of Murine Sarcoma and Is a Potent Adjuvant to Dendritic Cell Vaccination and Adoptive T-cell Therapy
    Duncan, Brynn B.
    Highfill, Steven L.
    Qin, Haiying
    Bouchkouj, Najat
    Larabee, Shannon
    Zhao, Peng
    Woznica, Iwona
    Liu, Yuxin
    Li, Youhua
    Wu, Wengen
    Lai, Jack H.
    Jones, Barry
    Mackall, Crystal L.
    Bachovchin, William W.
    Fry, Terry J.
    JOURNAL OF IMMUNOTHERAPY, 2013, 36 (08) : 400 - 411
  • [8] Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
    Kumar, Amrendra
    Ramani, Vijay
    Bharti, Vijaya
    Bellan, Daniel de Lima
    Saleh, Nabil
    Uzhachenko, Roman
    Shen, Chengli
    Arteaga, Carlos
    Richmond, Ann
    Reddy, Sangeetha M.
    Vilgelm, Anna
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (05)
  • [9] Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development
    Hosseinkhani, Negar
    Hemmat, Nima
    Baghbani, Elham
    Baghbanzadeh, Amir
    Kazemi, Tohid
    Mokhtarzadeh, Ahad
    Jafarlou, Mahdi
    Doustvandi, Mohammad Amin
    Baradaran, Behzad
    GENE, 2024, 896
  • [10] Photosensitizer IR700DX-6T-and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune responses during treatment of pancreatic cancer
    Zhang, Dawei
    Xie, Qing
    Liu, Yang
    Li, Zongyan
    Li, Haiyan
    Li, Shiying
    Li, Zhen
    Cui, Jing
    Su, Meng
    Jiang, Xiaofeng
    Xue, Ping
    Bai, Mingfeng
    PHARMACOLOGICAL RESEARCH, 2021, 172